Saturday 17 October 2026
Export RDNT’s income statement to Excel — free account
RadNet, Inc.
RDNT Healthcare Diagnostics & Research
RadNet, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.0 billion, up 11.5% from fiscal 2024. In the quarter to June 2026, revenue grew 25.0%, EPS fell 47.4%, free cash flow fell 43.2% and total debt rose 21.2%, each against the same quarter a year earlier. Revenue growth for five consecutive years, operating cash flow growth for three.
68.53
1.88
−2.67%
Follow RDNT
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
0.00 | 2,328.00 | 3,456.00 | 103.56 | 64.06 | 0.00 | 70.00 | 15.41 | 0.00 | 36.89 |
Piotroski F-Score |
3 | 4 | 6 | 4 | 7 | 3 | 5 | 5 | 6 | 5 |
Altman Z-Score |
2.04 | 2.25 | 1.45 | 0.88 | 1.23 | 0.88 | 1.12 | 1.11 | 1.43 | 1.26 |
P/S ratio |
2.63 | 2.79 | 1.36 | 0.73 | 1.20 | 0.93 | 0.87 | 0.50 | 0.51 | 0.34 |
P/FCF ratio |
119.74 | 1,669.14 | 958.69 | 33.99 | 129.12 | 7.09 | 32.19 | 10.32 | 5.73 | 9.06 |
Altman Z″-Score (non-manufacturers) |
1.40 | 1.77 | 0.95 | 0.01 | 0.17 | (0.37) | (0.09) | (0.11) | 0.25 | 0.28 |
Beneish M-Score |
(2.62) | (2.67) | (2.88) | (2.34) | (2.81) | (3.05) | (2.61) | (2.64) | (3.30) | (2.89) |
P/Operating CF |
63.74 | 119.94 | 24.71 | 19.56 | 32.13 | 15.71 | 46.43 | 16.93 | 7.07 | 8.14 |
P/B ratio |
3.96 | 4.50 | 2.70 | 2.14 | 4.57 | 3.86 | 4.33 | 2.44 | 6.74 | 5.77 |
Price to Tangible BV |
17.90 | 14.94 | 50.77 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Sales |
2.79 | 2.94 | 1.70 | 1.28 | 1.72 | 1.51 | 1.50 | 1.14 | 1.08 | 1.01 |
EV/EBITDA |
20.37 | 17.05 | 9.30 | 7.71 | 8.71 | 8.15 | 7.80 | 10.33 | 8.27 | 8.10 |
EV/Operating CF |
19.03 | 23.08 | 12.41 | 12.50 | 15.16 | 6.91 | 16.57 | 9.52 | 7.00 | 9.74 |
EV/FCF |
126.94 | 1,759.54 | 1,196.26 | 59.31 | 185.15 | 11.51 | 55.16 | 23.46 | 12.10 | 26.89 |
Quick Ratio |
1.65 | 1.93 | 1.16 | 0.63 | 0.72 | 0.58 | 0.60 | 0.67 | 1.08 | 1.19 |
Current Ratio |
1.76 | 2.12 | 1.32 | 0.79 | 0.87 | 0.68 | 0.74 | 0.87 | 1.23 | 1.40 |
Net Debt/EBITDA |
1.16 | 0.88 | 1.59 | 3.29 | 2.64 | 3.13 | 3.25 | 6.14 | 4.63 | 5.62 |
Debt/Assets |
29.00% | 30.92% | 30.18% | 37.36% | 39.86% | 40.39% | 46.14% | 60.58% | 70.09% | 75.24% |
Debt/Equity |
0.80 | 0.90 | 1.00 | 1.85 | 2.37 | 2.79 | 3.26 | 3.36 | 8.71 | 12.28 |
Asset Turnover |
0.58 | 0.61 | 0.63 | 0.64 | 0.68 | 0.62 | 0.84 | 0.99 | 1.07 | 1.05 |
Operating CF/Net income |
(16.02) | 83.43 | 72.56 | 13.75 | 6.05 | (15.75) | 7.07 | 3.62 | 2,683.49 | 12.68 |
Capex/Depreciation |
(0.98) | (0.89) | (0.90) | (0.60) | (0.80) | (0.57) | (0.48) | (0.90) | (0.85) | (0.82) |
Interest Coverage |
0.89 | 1.31 | 1.53 | 0.91 | 1.69 | 0.78 | 1.45 | 0.71 | 1.23 | 0.89 |
| (1.50%) | 0.29% | 0.47% | 2.54% | 8.18% | (6.04%) | 6.81% | 23.87% | 0.09% | 16.34% | |
| (0.53%) | 0.09% | 0.12% | 0.47% | 1.29% | (0.86%) | 1.07% | 3.26% | 0.01% | 0.86% | |
ROIC |
2.31% | 4.64% | 4.81% | 2.28% | 5.00% | 2.54% | 4.58% | 2.24% | 4.98% | 3.59% |
Return on Tangible Assets |
(1.49%) | 0.23% | 0.41% | 2.28% | 5.70% | (5.46%) | 5.24% | 10.24% | 0.02% | 2.33% |
Average Days of Receivables |
35.84 | 37.07 | 36.96 | 42.46 | 37.49 | 44.13 | 48.94 | 55.74 | 61.55 | 67.76 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Intangible Assets out of Total Assets |
0.28 | 0.24 | 0.29 | 0.32 | 0.28 | 0.29 | 0.29 | 0.41 | 0.34 | 0.33 |
Share Based Compensation of Revenue |
2.68% | 1.63% | 1.66% | 1.66% | 1.92% | 1.16% | 0.76% | 0.79% | 0.74% | 0.66% |
Graham Net Nets |
(0.26) | (0.22) | (0.59) | (1.50) | (0.88) | (1.26) | (1.16) | (1.43) | (1.20) | (1.93) |
Graham Number |
0.00 | 3.24 | 1.70 | 5.95 | 8.35 | 0.00 | 5.53 | 7.86 | 0.00 | 2.11 |
Earnings Yield |
(0.35%) | 0.04% | 0.03% | 0.97% | 1.56% | (1.53%) | 1.43% | 6.49% | 0.00% | 2.71% |
Free Cash Flow Yield |
0.84% | 0.06% | 0.10% | 2.94% | 0.77% | 14.10% | 3.11% | 9.69% | 17.45% | 11.04% |
Revenue per Share |
27.13 | 25.05 | 25.43 | 25.40 | 25.05 | 21.06 | 23.23 | 20.27 | 19.67 | 19.13 |
Operating CF per Share |
3.97 | 3.19 | 3.47 | 2.60 | 2.85 | 4.59 | 2.10 | 2.43 | 3.03 | 1.98 |
Capex per Share |
(2.82) | (2.57) | (2.78) | (2.05) | (2.71) | (1.83) | (1.47) | (1.44) | (1.28) | (1.26) |
Free Cash Flow per Share |
1.16 | 0.62 | 0.70 | 0.55 | 0.14 | 2.76 | 0.63 | 0.99 | 1.75 | 0.72 |
Cash per Share |
10.20 | 10.13 | 5.39 | 2.27 | 2.56 | 2.00 | 0.81 | 0.22 | 1.09 | 0.45 |
Shareholders Equity per Share |
18.03 | 15.52 | 12.79 | 8.73 | 6.59 | 5.08 | 4.69 | 4.16 | 1.49 | 1.13 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
18.03 | 15.52 | 12.79 | 8.73 | 6.59 | 5.08 | 4.69 | 4.16 | 1.49 | 1.13 |
Free Cash Flow |
86.86 | 45.11 | 44.35 | 30.87 | 7.11 | 140.42 | 31.33 | 47.40 | 82.23 | 33.17 |
Working Capital |
445.36 | 539.54 | 141.82 | (99.54) | (50.52) | (127.69) | (86.25) | (30.83) | 43.75 | 62.57 |
Capital Expenditures |
(211.96) | (187.91) | (176.52) | (115.55) | (142.38) | (93.34) | (72.99) | (69.36) | (59.99) | (58.47) |
Net Current Asset Value |
(1,370.55) | (1,134.03) | (1,297.84) | (1,575.27) | (1,388.05) | (1,257.93) | (1,172.67) | (700.39) | (563.70) | (579.51) |
EV/EBIT |
91.75 | 51.40 | 27.78 | 39.49 | 27.46 | 45.28 | 24.73 | 36.00 | 19.88 | 23.18 |
Capex to Sales |
0.10 | 0.10 | 0.11 | 0.08 | 0.11 | 0.09 | 0.06 | 0.07 | 0.07 | 0.07 |
Price to Operating Income |
86.54 | 48.76 | 22.26 | 22.63 | 19.15 | 27.91 | 14.43 | 15.84 | 9.41 | 7.81 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.27 | 0.30 | 0.32 | 0.34 | 0.37 | 0.41 | 0.41 | 0.22 | 0.29 | 0.29 |
Cash ROIC |
2.70% | 1.56% | 2.25% | 2.02% | 0.55% | 12.98% | 3.03% | 5.37% | 11.26% | 4.66% |
Accounts Receivable Turnover |
10.57 | 10.47 | 9.80 | 9.49 | 9.94 | 7.54 | 7.60 | 6.41 | 5.77 | 5.41 |
Accounts Payable Turnover |
4.67 | 4.55 | 3.92 | 3.99 | 4.49 | 4.35 | 5.14 | 5.48 | 6.50 | 6.90 |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Days of Payables |
85.35 | 81.16 | 89.71 | 106.70 | 85.76 | 89.44 | 75.79 | 76.16 | 61.78 | 52.30 |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Receivables |
193.07 | 174.76 | 165.03 | 150.71 | 132.32 | 142.17 | 151.84 | 152.22 | 159.86 | 163.53 |
Average Payables |
386.75 | 347.20 | 356.27 | 316.77 | 250.31 | 222.13 | 194.31 | 158.42 | 123.49 | 112.49 |
Average Assets |
3,522.63 | 2,988.58 | 2,562.19 | 2,246.19 | 1,922.57 | 1,716.82 | 1,378.16 | 989.15 | 859.23 | 842.95 |
Average Common Equity |
1,244.65 | 973.38 | 652.41 | 418.80 | 302.23 | 245.72 | 216.70 | 135.09 | 60.99 | 44.26 |
Columns are period end dates